We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this article, we are going to take a look at where Solventum Corporation (NYSE:SOLV) stands against the other health information services stocks.
Health Information Services stocks have become a key focus for investors as AI starts to enter more domains in 2025. Some of the most amazing gains have come in health information services stocks that are utilizing AI to improve research and services in the healthcare sector.
The healthcare information services sector allows investors to gain exposure to a number of growing and emerging technologies including cloud-backed software solutions to physician enablement platforms. Some of the companies in our list are surging based on earnings anticipation while others are increasing in share price because of their upcoming products or revenue growth.
To come up with our list of top 10 health information services stocks outpacing the broader market in 2025, we only considered stocks with a market cap of at least $2 billion that were outperforming the S&P 500 index.
A smiling healthcare professional, treating a patient with the PLEX platform.
Solventum Corporation (NYSE:SOLV)
Solventum Corporation (NYSE:SOLV) is a healthcare company that manufactures, develops, and markets a range of solutions for critical patient and customer needs. The company operates in dental solutions, filtration & purification, MedSurg, and health information systems segments. Its stock is up 12% so far this year.
Solventum Corporation (NYSE:SOLV) is a spinoff from 3M Company (MMM) and is currently facing activist investor pressure. Nelson Peltz, a billionaire investor, has a 5% stake in the company and is pushing the company to do better, which is one factor driving its recent rally.
When the company was under 3M, it was doing much better than it is doing now, a sentiment summed up perfectly by Trian Fund Management, Peltz’s firm:
In a short period of time, Solventum went from consistently growing organically at a low-to-midsingle digit rate at a mid-to-high 20% operating margin – to a business that is barely growing today at a low-20% operating margin, despite its core end markets continuing to perform well.
The stock is up 50% since Trian first disclosed its stake in the company. However, there is still no clear evidence of whether the management is taking any concrete measures to please the activist investor or change the company’s fortunes.
Overall SOLV ranks 10th on our list of the health information services stocks outpacing the market in 2025. While we acknowledge the potential of SOLV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as SOLV but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article was originally published at Insider Monkey.
